Corti Therapeutics is a seed-stage biotechnology company focusing on developing the next generation of lipid nanoparticle technology for selective and efficient extrahepatic delivery. Our technology has tunable cell selectivity and high developability. We are founded by industry leaders.
Company Details
- Employees
- 4
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Corti Therapeutics Questions
Corti Therapeutics's LinkedIn profile is https://www.linkedin.com/company/corti-therapeutics
Corti Therapeutics has
4 employees.
View email and phone details for 4
employees at Corti Therapeutics.
Corti Therapeutics's industry is
Biotechnology Research
Corti Therapeutics's top competitors are
Sanegenebio,
Life Edit Therapeutics,
Orna Therapeutics,
Oncorus,
Vesigen Therapeutics, Inc.,
Modex Therapeutics Inc,
Onchilles Pharma,
Kisbee Therapeutics,
Refactor Biosciences,
Omega Therapeutics.
Corti Therapeutics's categories are Biotechnology Research
